RE:RE:RE:RE:RE:SP Moving in Chunks Today! If I might add to this question from Spammmm...I don't claim to be an expert on Standard Of Care at ICUs but if PMX was to be awarded a New SOC or companion to SOC and someone comes into the ICU...goes into Septic Shock...then progresses into ENDOTOXIC Septic Shock and Our EAA Diagnostic starts showing a continued rise in Endotoxins, could a doctor immediately prescribe the PMX being it Instantly Begins removing the Endotoxins which could stop the patient from going into the Fatal Stages of Endo-Septic-Shock....
Remember not all of the 270,000 who go into Endo-Septic-Shock die....and knowone knows for sure who will die....but PMX Treatment could prevent the patient from going into the fatal stages or from potential organ failures which could also be prevented by early treatment of the PMX.
If I am a patient or one of my family is a patient who is progressing into Endo-Septic-Shock and my Doctor knows that PMX is a Proven Solution then it's a No Brainer to prescribe the PMX Treatment ASAP!
Now that changes the whole picture as to who can potentially receive the PMX and a Much Larger Audience and Financial Market Potential.
The Key to the Trial is to show it Removes Endotoxins In The Worst Possible Scenario and thereby Proving it can also be potentially used in a Preventative way especially if it is awarded SOC.
Not to mention as MM has stated many times and I quote " "And the addressable target may even expand depending on Bayesian analysis, EDEN studies, other real world studies, Euphas2, cautious doctors, etc etc ".....and even severe COVID where PMX has been proven effective!
Creates a whole different End Game and Potential Value!
IMHO and for it is worth:)
Rev